Login to Your Account



NPS Jumps on Earnings, Gattex Sales Guidance

By Catherine Shaffer
Staff Writer

Friday, August 9, 2013
NPS Pharmaceuticals Inc., of Bedminster, N.J., racked up $4.8 million in Gattex (teduglutide) sales in the second quarter of 2013, with expectations of $25 million to $30 million in net sales for the full year.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription